(Q53928519)

English

OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143.

scientific article

Statements

OS10.3 of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143 (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit